A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

NCT05832151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Gastroparesis

Interventions

DRUG: CIN-102 Dose 15mg or 10mg
DRUG: Placebo

Sponsor

CinDome Pharma, Inc.